Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.

Huang RY, Eppolito C, Lele S, Shrikant P, Matsuzaki J, Odunsi K.

Oncotarget. 2015 Sep 29;6(29):27359-77. doi: 10.18632/oncotarget.4751.

2.

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, Beck A, Miller A, Tsuji T, Eppolito C, Qian F, Lele S, Shrikant P, Old LJ, Odunsi K.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80. doi: 10.1073/pnas.1003345107. Epub 2010 Apr 12.

3.

Regulating functional cell fates in CD8 T cells.

Shrikant PA, Rao R, Li Q, Kesterson J, Eppolito C, Mischo A, Singhal P.

Immunol Res. 2010 Mar;46(1-3):12-22. doi: 10.1007/s12026-009-8130-9. Review.

4.

Antigen-induced Erk1/2 activation regulates Ets-1-mediated sensitization of CD8+ T cells for IL-12 responses.

Li Q, Eppolito C, Odunsi K, Shrikant PA.

J Leukoc Biol. 2010 Feb;87(2):257-63. doi: 10.1189/jlb.0409221. Epub 2009 Oct 20.

5.

Angiostatic activity of the antitumor cytokine interleukin-21.

Castermans K, Tabruyn SP, Zeng R, van Beijnum JR, Eppolito C, Leonard WJ, Shrikant PA, Griffioen AW.

Blood. 2008 Dec 15;112(13):4940-7. doi: 10.1182/blood-2007-09-113878. Epub 2008 May 30.

6.

The acute phase protein haptoglobin regulates host immunity.

Huntoon KM, Wang Y, Eppolito CA, Barbour KW, Berger FG, Shrikant PA, Baumann H.

J Leukoc Biol. 2008 Jul;84(1):170-81. doi: 10.1189/jlb.0208100. Epub 2008 Apr 24.

7.

Characterizing host immune responses by monitoring fluorescently marked cells.

Mischo A, Eppolito C, Li Q, Shrikant PA.

Immunol Invest. 2007;36(5-6):791-805. No abstract available.

PMID:
18161529
8.

IL-12-programmed long-term CD8+ T cell responses require STAT4.

Li Q, Eppolito C, Odunsi K, Shrikant PA.

J Immunol. 2006 Dec 1;177(11):7618-25.

9.

Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity.

Tao J, Segal BH, Eppolito C, Li Q, Dennis CG, Youn R, Shrikant PA.

J Leukoc Biol. 2006 Sep;80(3):529-37. Epub 2006 Jun 22.

PMID:
16793916
10.

Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.

Bolesta E, Kowalczyk A, Wierzbicki A, Eppolito C, Kaneko Y, Takiguchi M, Stamatatos L, Shrikant PA, Kozbor D.

J Immunol. 2006 Jul 1;177(1):177-91.

11.

The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity.

Vingert B, Adotevi O, Patin D, Jung S, Shrikant P, Freyburger L, Eppolito C, Sapoznikov A, Amessou M, Quintin-Colonna F, Fridman WH, Johannes L, Tartour E.

Eur J Immunol. 2006 May;36(5):1124-35.

12.

IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21.

Moroz A, Eppolito C, Li Q, Tao J, Clegg CH, Shrikant PA.

J Immunol. 2004 Jul 15;173(2):900-9.

13.

Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis.

Berleth ES, Nadadur S, Henn AD, Eppolito C, Shiojiri S, Gurtoo HL, Ehrke MJ, Mihich E.

Cancer Res. 1999 Nov 1;59(21):5497-506.

14.

Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice.

Ehrke MJ, Verstovsek S, Ujházy P, Meer JM, Eppolito C, Maccubbin DL, Mihich E.

Cancer Immunol Immunother. 1998 Feb;45(6):287-98.

PMID:
9490198
15.

Murine splenic macrophage tumoricidal activation by cytokines.

Verstovsek S, Eppolito C, Ujhazy P, Maccubbin DL, Ehrke MJ, Mihich E.

Exp Hematol. 1995 Jun;23(6):519-28.

PMID:
7768308
16.

TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells.

Ujházy P, Maccubbin D, Eppolito C, Mihich E, Ehrke MJ.

Lymphokine Cytokine Res. 1994 Apr;13(2):99-106.

PMID:
8061121
17.

Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.

Ho RL, Maccubbin DL, Ujházy P, Zaleskis G, Eppolito C, Mihich E, Ehrke MJ.

Oncol Res. 1993;5(9):363-72.

PMID:
8038457
18.
19.

The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigens.

Ehrke MJ, Reino JM, Eppolito C, Mihich E.

Int J Immunopharmacol. 1983;5(1):35-42.

PMID:
6220984
20.

Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.

Orsini F, Eppolito C, Ehrke MJ, Mihich E.

Cancer Treat Rep. 1980 Feb-Mar;64(2-3):211-8. No abstract available.

PMID:
6967756

Supplemental Content

Loading ...
Support Center